C21 Investments Inc.: Form 6-K - Filed by newsfilecorp.com

0001062993-22-023917.txt : 20221215 0001062993-22-023917.hdr.sgml : 20221215 20221215104622 ACCESSION NUMBER: 0001062993-22-023917 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221215 DATE AS OF CHANGE: 20221215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: C21 Investments Inc. CENTRAL INDEX KEY: 0000831609 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55982 FILM NUMBER: 221463987 BUSINESS ADDRESS: STREET 1: SUITE 820, 1075 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 3N9 BUSINESS PHONE: 604-336-8613 MAIL ADDRESS: STREET 1: SUITE 820, 1075 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 3N9 FORMER COMPANY: FORMER CONFORMED NAME: CURLEW LAKE RESOURCES INC DATE OF NAME CHANGE: 20121129 FORMER COMPANY: FORMER CONFORMED NAME: CURLEW LAKE RESOURCES INC /FI DATE OF NAME CHANGE: 19880409 6-K 1 form6k.htm FORM 6-K C21 Investments Inc.: Form 6-K - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

For the month of December 2022.

Commission File Number 000-55982

C21 INVESTMENTS INC.
(Translation of registrant’s name into English)

Suite 1900-855 West Georgia St
Vancouver BC, V6C 3H4
Canada
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

Form 20-F [X] Form 40-F [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	C21 INVESTMENTS INC.

Date: December 15, 2022	/s/ Michael Kidd
	Michael Kidd
	Chief Financial Officer

-2-

INDEX TO EXHIBITS

Exhibit		Description

99.1		Q3 Financial Statements October 31, 2022
99.2		Q3 Management Discussion and Analysis October 31, 2022
99.3		Q3 CEO Certification
99.4		Q3 CFO Certification

EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 C21 Investments Inc.: Exhibit 99.1 - Filed by newsfilecorp.com

C21 INVESTMENTS INC.

	Interim Condensed Consolidated Financial Statements
	For the three and nine months ended October 31, 2022 and 2021
	(Expressed in U.S. Dollars)

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS	1

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME	2

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY	3

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS	4

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	5-23

Notice of Disclosure of Non-auditor Review of the Interim Condensed Consolidated Financial Statements for the three and nine months ended October 31, 2022 and 2021.

Pursuant to National Instrument 51-102, Part 4, subsection 4.3(3)(a) issued by the Canadian Securities administrators, if an auditor has not performed a review of the interim financial statements, they must be accompanied by a notice indicating that the financial statements have not been reviewed by an auditor.

The accompanying unaudited interim condensed consolidated financial statements of C21 Investments Inc. (the "Company" or "C21") for the interim period ended October 31, 2022, have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and are the responsibility of the Company's management.

The Company's independent auditors, Marcum, LLP, have not performed a review of these interim condensed consolidated financial statements.

December 15, 2022

C21 INVESTMENTS INC.
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
As at October 31, 2022 and January 31, 2022
(Expressed in U.S. dollars) - Unaudited

	October 31, 2022		January 31, 2022
	$		$
ASSETS
Current assets
Cash	2,309,792		3,067,983
Receivables	260,840		210,423
Inventory	5,549,227		4,054,473
Prepaid expenses and deposits	441,429		773,450
Current portion of assets classified as held for sale	2,042,268		2,178,145
	10,603,556		10,284,474
Non-current assets
Property and equipment	4,811,817		4,869,593
Right-of-use assets	8,511,157		8,875,884
Intangible assets	8,221,160		9,224,165
Goodwill	28,541,323		28,541,323
Restricted cash	45,844		49,011
Deferred tax asset	549,580		9,024
TOTAL ASSETS	61,284,437		61,853,474

LIABILITIES
Current liabilities
Accounts payable and accrued liabilities	2,387,890		2,508,869
Promissory note payable - current portion	3,546,667		6,080,000
Convertible promissory notes - current portion	1,156,259		1,281,442
Income taxes payable	6,336,322		3,658,162
Lease liabilities - current portion	379,711		325,698
Current portion of liabilities classified as held for sale	697,626		874,379
	14,504,475		14,728,550
Non-current liabilities
Lease liabilities	8,660,493		8,953,425
Deposit liability	175,000		100,000
Promissory note payable	-		2,026,667
Derivative liability	219,796		1,006,368
Reclamation obligation	51,506		55,272
TOTAL LIABILITIES	23,611,270		26,870,282

SHAREHOLDERS' EQUITY
Common stock, no par value; unlimited shares authorized; 120,047,814 and 117,057,860 shares issued and outstanding as at October 31, 2022 and January 31, 2022, respectively	105,424,989		105,236,351
Commitment to issue shares	628,141		628,141
Accumulated other comprehensive loss	(2,282,000	)	(2,370,967	)
Deficit	(66,097,963	)	(68,510,333	)
TOTAL SHAREHOLDERS' EQUITY	37,673,167		34,983,192
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	61,284,437		61,853,474

On behalf of the Board:

"Bruce Macdonald"	Director	"Michael Kidd"	Director

See accompanying notes to the interim condensed consolidated financial statements

p. 1

C21 INVESTMENTS INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
For the three and nine months ended October 31, 2022 and 2021
(Expressed in U.S. dollars) - Unaudited

	Three months ended October 31				Nine months ended October 31
	2022		2021		2022		2021
	$		$		$		$

Revenue	7,207,404		7,938,188		21,855,358		25,328,410
Cost of sales	3,303,066		3,485,632		10,104,051		10,485,735
Gross profit	3,904,338		4,452,556		11,751,307		14,842,675

Selling, general and administrative expense	2,528,779		2,356,551		7,156,869		6,838,329

Income from operations	1,375,559		2,096,005		4,594,438		8,004,346

Impairment loss	-		-		(20,726	)	-
Interest expense	(98,657	)	(242,645	)	(396,161	)	(870,952	)
Accretion expense	-		-		-		(230,462	)
Other (expense) income	(13,173	)	23,132		(10,273	)	137,738
Gain on change in fair value of derivative liabilities	127,813		2,392,019		757,313		8,260,347
Net income from continuing operations before income taxes	1,391,542		4,268,511		4,924,591		15,301,017
Income tax expense	(1,154,189	)	(1,171,331	)	(2,137,604	)	(3,091,376	)
Net income from continuing operations after income taxes	237,353		3,097,180		2,786,987		12,209,641

Net income (loss) from discontinued operations after income taxes	11,154		(259,448	)	(374,617	)	(261,785	)

NET INCOME	248,507		2,837,732		2,412,370		11,947,856

Other comprehensive loss
Cumulative translation adjustment	305,354		(21,737	)	88,967		(854,280	)
COMPREHENSIVE INCOME	553,861		2,815,995		2,501,337		11,093,576
Basic income per share from continuing operations	0.00		0.03		0.02		0.10
Diluted income per share from continuing operations	0.00		0.03		0.02		0.10
Basic and diluted income (loss) per share from discontinued operations	0.00		(0.00	)	(0.00	)	(0.00	)
Basic income per share	0.00		0.02		0.02		0.10
Diluted income per share	0.00		0.02		0.02		0.10
Weighted average number of common shares outstanding - basic	120,047,814		118,127,232		120,047,814		118,127,232
Weighted average number of common shares outstanding - diluted	122,880,907		121,580,907		122,880,907		121,580,907

See accompanying notes to the interim condensed consolidated financial statements

p. 2

C21 INVESTMENTS INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
For the nine months ended October 31, 2022 and 2021
(Expressed in U.S. dollars, except number of shares) - Unaudited

	Number of shares	Common stock	Commitment to issue shares		Accumulated other comprehensive loss		Deficit		Total
	#	$	$		$		$		$
Balance at January 31, 2021	117,057,860	103,636,830	649,928		(1,604,126	)	(79,426,484	)	23,256,148
Commitment to issue shares on purchase of EFF	19,774	21,787	(21,787	)	-		-		-
Shares issued on exercise of Phantom Farms warrants	456,100	533,326	-		-		-		533,326
Shares issued on exercise of guarantee warrants	1,214,080	-	-		-		-		-
Shares-based compensation	-	321,567	-		-		-		321,567
Net income and other comprehensive loss for the period	-	-	-		(854,283	)	11,947,856		11,093,573
Balance at October 31, 2021	118,747,814	104,513,510	628,141		(2,458,409	)	(67,478,628	)	35,204,614

Balance at January 31, 2022	120,047,814	105,236,351	628,141		(2,370,967	)	(68,510,333	)	34,983,192
Share-based compensation	-	188,638	-		-		-		188,638
Net income and other comprehensive income for the period	-	-	-		88,967		2,412,370		2,501,337
Balance at October 31, 2022	120,047,814	105,424,989	628,141		(2,282,000	)	(66,097,963	)	37,673,167

See accompanying notes to the interim condensed consolidated financial statements

p. 3

C21 INVESTMENTS INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the nine months ended October 31, 2022 and 2021
(Expressed in U.S. dollars) - Unaudited

	Nine months ended October 31,
	2022		2021
	$		$
OPERATING ACTIVITIES
Net income from continuing operations	2,786,987		12,209,641
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,380,852		1,015,196
Share-based compensation	188,638		321,567
Impairment loss	20,726		-
Interest expense	26,127		9,442
Accretion expense	-		230,402
Deferred income tax (recovery) expense	(540,556	)	476,900
Foreign exchange gain	(27,543	)	-
Gain on change in fair value of derivative liabilities	(757,313	)	(8,260,347	)
Loss on sale of assets	-		9,077
Changes in operating assets and liabilities:
Inventory	(1,494,754	)	(1,394,179	)
Prepaid expenses and deposits	332,022		(155,792	)
Receivables	(50,417	)	64,971
Accounts payable and accrued liabilities	86,795		2,074,291
Income taxes payable	2,678,160		(531,417	)
Lease liabilities	125,808		270,305
Cash provided by operating activities of continuing operations	4,755,532		6,340,057
Cash used in operating activities of discontinued operations	(55,934	)	(1,534,452	)

INVESTING ACTIVITIES
Purchases of property and equipment	(433,214	)	(2,432,493	)
Cash used in investing activities of continuing operations	(433,214	)	(2,432,493	)
Cash provided by investing activities of discontinued operations	51,357		1,178,650

FINANCING ACTIVITIES
Principal repayments on promissory note payable	(4,560,000	)	(4,560,000	)
Repayments of convertible promissory notes	(40,000	)	(1,210,000	)
Cash proceeds from warrants	-		533,326
Interest paid in cash	(432,954	)	(883,128	)
Cash used in financing activities of continuing operations	(5,032,954	)	(6,119,802	)
Cash used in financing activities of discontinued operations	(46,762	)	(91,492	)

Effect of foreign exchange on cash	3,784		(298,657	)
Decrease in cash during the period	(758,191	)	(2,958,189	)
Cash beginning of period	3,067,983		6,237,182
Cash end of period	2,309,792		3,278,993

Supplemental disclosure of cash flow information
Income taxes paid in cash	-		3,145,893

Non-cash financing activities
Common shares issued as partial settlement of commitment to issue shares	-		21,787

See accompanying notes to the interim condensed consolidated financial statements

p. 4

C21 INVESTMENTS INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and nine months ended October 31, 2022 and 2021
(Expressed in U.S. dollars, except as noted) - Unaudited

1. NATURE OF OPERATIONS

C21 Investments Inc. (the "Company" or "C21") was incorporated January 15, 1987, under the Company Act of British Columbia. The Company is a publicly traded company with its registered office is 170-601 West Cordova Street, Vancouver, BC, V6B 1G1.

Pursuant to a change of business announced on January 29, 2018 to the Cannabis industry, the Company commenced acquiring and operating revenue-producing cannabis operations in the USA.

On June 15, 2018, the Company's common shares were delisted from the TSX Venture Exchange ("TSX-V") at the Company's request and on June 18, 2018 the Company commenced trading on the Canadian Securities Exchange ("CSE"), completed its change of business to the cannabis industry and commenced trading under the symbol CXXI. The Company registered its common shares in the United States and on May 6, 2019, its shares were cleared by the Financial Industry Regulatory Authority for trading on the OTC Markets platform under the U.S. trading symbol CXXIF. On September 28, 2020, the Company began trading on the OTCQB® Venture Market.

For the year ended January 31, 2021, the Company operated in two segments: recreational cannabis in Oregon, USA and recreational and medical cannabis in Nevada, USA (Note 15). During the year ended January 31, 2022, the Company made the strategic decision to exit operations in Oregon. The comparative results of operations have been re-stated to present the operating results of the Oregon segment as discontinued operations. The Nevada segment remains engaged in the cultivation of and manufacturing of cannabis flower products, vape products and extract products for wholesale and retail sales.

At October 31, 2022, the Company had cash of $2,309,792, a working capital deficiency of $3,900,919 and an accumulated deficit of $66,097,963. However, for the period ended October 31, 2022, the Company generated net income and positive cash flows from operations.

Management has taken several actions to ensure that the Company will continue as a going concern through October 31, 2023, including the closing of its operations in Oregon (Note 4), selling the assets in Oregon, reducing headcount, and reducing discretionary expenditures. The Company is seeking additional financing in the form of debt, which could consolidate existing debt on its balance sheet on more favorable terms. Management believes that these actions will enable the Company to continue as a going concern through December 15, 2023, one year from the date these consolidated financial statements were issued.

In the United States, 36 states, the District of Columbia, and four out of five U.S. territories allow the use of medical cannabis. The recreational adult-use of cannabis is legalized in 17 states, including Alaska, Arizona, California, Colorado, Illinois, Maine, Massachusetts, Michigan, Montana, Nevada, New Jersey, New Mexico, New York, Oregon, Vermont, Virginia, Washington, and the District of Columbia. At the federal level, however, cannabis currently remains a Schedule I controlled substance under the Federal Controlled Substances Act of 1970. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of accepted safety for the use of the drug under medical supervision. As such, even in those states in which marijuana is legalized under state law, the manufacture, importation, possession, use or distribution of cannabis remains illegal under U.S. federal law. This has created a dichotomy between state and federal law, whereby many states have elected to regulate and remove state-level penalties regarding a substance which is still illegal at the federal level. There remains uncertainty about the US federal government's position on cannabis with respect to cannabis-legal status. A change in its enforcement policies could impact the ability of the Company to continue as a going concern.

p. 5

2. BASIS OF PREPARATION

Basis of presentation

These unaudited interim condensed consolidated financial statements as at and for the three and nine months ended October 31, 2022 and 2021 ("consolidated financial statements") are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These consolidated financial statements have been prepared on an accrual basis and are based on historical costs, except for certain financial instruments classified as fair value through profit or loss.

Functional and reporting currency

The functional currency of C21 Investments Inc. is Canadian dollars ("C$"), and the functional currency of the Company's subsidiaries is U.S. dollars. C21 has determined that the U.S. dollar ("USD") is the most relevant and appropriate reporting currency as the Company's operations are conducted in U.S. dollars and its financial results are prepared and reviewed internally by management in U.S. dollars. The consolidated financial statements are presented in U.S. dollars unless otherwise noted.

Basis of consolidation

The consolidated financial statements incorporate the accounts of the Company and all the entities in which the Company has a controlling voting interest and is deemed to be the primary beneficiary. All consolidated entities were under common control during the entirety of the periods for which their respective results of operations were included in the consolidated statements from the date of acquisition. All intercompany balances and transactions are eliminated upon consolidation.

The following are the Company's subsidiaries that are included in these interim financial statements as at and for the period ended October 31, 2022:

Name of Subsidiary	Country of Incorporation	Percentage Ownership	Functional Currency	Principal Activity
320204 US Holdings Corp.	USA	100%	USD	Holding Company
320204 Oregon Holdings Corp.	USA	100%	USD	Holding Company
320204 Nevada Holdings Corp.	USA	100%	USD	Holding Company
320204 Re Holdings, LLC	USA	100%	USD	Holding Company
Eco Firma Farms LLC	USA	100%	USD	Cannabis producer
Silver State Cultivation LLC	USA	100%	USD	Cannabis producer
Silver State Relief LLC	USA	100%	USD	Cannabis retailer
Swell Companies LTD	USA	100%	USD	Cannabis processor, distributor
Megawood Enterprises Inc.	USA	100%	USD	Cannabis retailer
Phantom Venture Group, LLC	USA	100%	USD	Holding Company
Phantom Brands, LLC	USA	100%	USD	Holding Company
Phantom Distribution, LLC	USA	100%	USD	Cannabis distributor
63353 Bend, LLC	USA	100%	USD	Cannabis producer
20727-4 Bend, LLC	USA	100%	USD	Cannabis processor
4964 BFH, LLC	USA	100%	USD	Cannabis producer
Workforce Concepts 21, Inc.	USA	100%	USD	Payroll and benefits services

3. SIGNIFICANT ACCOUNTING POLICIES

The Company's significant accounting policies are more fully described in Note 3 to the consolidated financial statements for the years ended January 31, 2022 and December 31, 2021. There have been no material changes to the Company's significant accounting policies.

p. 6

3. SIGNIFICANT ACCOUNTING POLICIES (Continued)

Significant accounting estimates and assumptions

The preparation of the Company's financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities and contingent liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and assumptions are continuously evaluated and are based on management's experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from those estimates and judgments.

Areas requiring a significant degree of estimation and judgment relate to the determination of fair values of assets acquired and liabilities assumed in business combinations, impairment of long-lived assets and inventory, fair value measurements, useful lives, depreciation and amortization of property, equipment and intangible assets, the recoverability and measurement of deferred tax assets and liabilities, share-based compensation, and fair value of derivative liabilities.

Recently issued accounting pronouncements

Recent accounting pronouncements, other than those below, issued by the FASB, the American Institute of Certified Public Accountants ("AICPA") and the U.S. Securities and Exchange Commission ("SEC") did not or are not believed by management to have a material effect on the Company's present or future financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ("ASU 2021-08"), which requires an acquirer to recognize and measure contract assets and liabilities acquired in a business combination in accordance with Revenue from Contracts with Customers ("Topic 606") rather than adjust them to fair value at the acquisition date. ASU 2021-08 is effective for fiscal periods beginning after December 15, 2022. The Company does not expect the adoption of this standard to have any material impact on the consolidated financial statements.

4. DISCONTINUED OPERATIONS

In January 2022, the Company entered into to a lease-to-own arrangement with a lessee for certain licenses, land and equipment in Oregon, USA, representing its outdoor growing operation. The lease-to-own arrangement concludes in January 2027 with total undiscounted payments over the term amounting to $2,514,805. The Company determined that the arrangement should be accounted for as a sales-type lease and concluded that it is not probable that all required payments will be made such that title will transfer at the end of the term. As such, in accordance with ASC 842, the land and equipment have not been derecognized and payments received will be recorded as a deposit liability until such time that collectability becomes probable. As at October 31, 2022, $175,000 has been received under the arrangement and has been recorded as a deposit liability.

As a result of non-profitable operations in the Oregon reporting unit, the Company began to wind down operations in Oregon beginning in the year ended January 31, 2021. At January 31, 2021, the Company classified the assets and liabilities in Swell and Megawood as held for sale and completed the sale of these assets in April 2021. By January 31, 2022, the Company made the decision to cease all growing, manufacturing, and processing activities in Bend, Oregon. As the Oregon reporting unit comprises the assets of multiple components in distinct geographic locations, management anticipates completing the sale on a piecemeal basis. Management is engaged in an active program to seek buyers for the major classes of assets and liabilities in Oregon in order to complete a sale in the next twelve months.

p. 7

4. DISCONTINUED OPERATIONS (Continued)

Prepaid expenses classified as held for sale primarily relates to the renewal of licenses that may be transferred in the event of a sale. Otherwise, prepaid expenses will be expensed within loss from discontinued operations over the next twelve months.

Long-term debt consists of vehicle loans and a building mortgage. The mortgage began on February 1, 2015 and matures on January 1, 2035 (20 years). The mortgage bears interest at a fixed rate of 4.5% with payments made monthly. The equipment and vehicle loans consist of three loans with maturity dates ranging from June 1, 2021 through May 15, 2023 and interest rates ranging from 5.59% to 19.9% with payments made monthly.

The following table summarizes the major classes of assets and liabilities of the discontinued Oregon operation that have been classified as held-for-sale in the consolidated balance sheets:

	October 31, 2022		January 31, 2022
	$		$
Carrying amounts of the major classes of assets included in discontinued operations:
Receivables	464,468		64,456
Inventory	-		363,391
Prepaid expenses and deposits	59,708		111,617
Deferred tax asset	152,177		152,177
Property and equipment	1,139,517		1,139,517
Right-of-use assets	226,398		346,987
Total assets classified as held for sale	2,042,268		2,178,145
Current portion of assets classified as held for sale	(2,042,268	)	(2,178,145	)
Non-current portion of assets classified as held for sale	-		-
	-
Carrying amounts of the major classes of liabilities included in discontinued operations:
Lease liabilities	267,089		412,093
Long-term debt	430,537		462,286
Total liabilities classified as held for sale	697,626		874,379
Current portion of liabilities classified as held for sale	(697,626	)	(874,379	)
Non-current portion of liabilities classified as held for sale	-		-

As at October 31, 2022, receivables classified as held for sale contained $265,730 of income taxes receivable (January 31, 2022 - $nil).

p. 8

4. DISCONTINUED OPERATIONS (Continued)

The following table provides the major classes of line items constituting pre-tax loss from discontinued operations:

	Three months ended October 31,				Nine months ended October 31,
	2022		2021		2022		2021
	$		$		$		$
Revenue	-		218,398		357,540		954,175
Cost of sales	(3,311	)	400,229		473,894		1,134,189
Gross profit (loss)	3,311		(181,831	)	(116,354	)	(180,014	)

Expenses (income)
General and administration	59,656		81,088		255,231		276,956
Sales, marketing, and promotion	-		7,724		1,939		59,520
Operating lease cost	48,909		-		146,729		1,233
Depreciation and amortization	10,837		42,655		20,756		164,664
Impairment loss	-		-		61,937		-
Provision for expected credit losses	-		-		35,359		-
Other income	4,892		11,939		2,042		(354,320	)
Net loss from discontinued operations	(120,983	)	(325,237	)	(640,347	)	(328,067	)
Income tax recovery	132,137		65,789		265,730		66,282
Net income (loss) from discontinued operations after income taxes	11,154		(259,448	)	(374,617	)	(261,785	)

The following table summarizes the cash flows from discontinued operations:

	October 31, 2022		October 31, 2021
	$		$
Net cash used in operating activities of discontinued operations	(55,934	)	(1,534,452	)
Net cash provided by investing activities of discontinued operations	51,357		1,178,650
Net cash used in financing activities of discontinued operations	(46,762	)	(91,492	)

5. RECEIVABLES

	October 31, 2022	January 31, 2022
	$	$
Taxes receivable	7,874	11,945
Trade receivables	252,966	198,478
	260,840	210,423

There was no provision for expected credit losses on trade receivables at October 31, 2022 or January 31, 2022.

p. 9

6. INVENTORY

	October 31, 2022	January 31, 2022
	$	$
Finished goods	2,614,857	1,848,392
Work in process	2,490,461	2,029,133
Raw materials	443,909	176,948
	5,549,227	4,054,473

7. PROPERTY AND EQUIPMENT AND RIGHT-OF-USE ASSETS

Property and equipment

The following table summarizes the Company's property and equipment:

	October 31, 2022		January 31, 2022
	$		$
Land	1,330,000		1,330,000
Leasehold improvements	1,900,673		1,758,229
Furniture & fixtures	334,540		460,890
Computer equipment	6,513		46,484
Machinery & equipment	2,450,919		2,305,217
	6,022,645		5,900,820
Less: accumulated depreciation	(1,210,828	)	(1,031,227	)
	4,811,817		4,869,593

Total depreciation expense for the three and nine months ended October 31, 2022 was $134,988 and $398,603 respectively (2021 - $122,132 and $359,067, respectively). Of the total depreciation expense, $120,382 and $351,816 was allocated to inventory (2021 - $68,458 and $153,719, respectively).

At January 31, 2022, the Company reclassified buildings with a cost of $1,370,212 and accumulated depreciation of $230,695 to assets classified as held for sale. The prior period comparative amounts of cost of $1,370,212 and accumulated depreciation of $202,072 were also re-classified.

Right-of-use assets

The Company's right-of-use assets result from its operating leases (Note 10) and consist of land and buildings used in the cultivation, processing, and warehousing of its products.

At October 31, 2022, assets classified as held for sale contains right-of-use assets with a carrying value of $226,398 (January 31, 2022 - $346,987). Management estimated the fair value less costs to sell exceeds the carrying value and therefore the assets are measured at their carrying values.

p. 10

8. INTANGIBLE ASSETS AND GOODWILL

Intangible assets

The following table summarizes the Company's intangible assets:

	October 31, 2022		January 31, 2022
	$		$
Licenses	12,167,022		12,141,476
Brands	644,800		868,982
Customer relationships	1,540,447		1,758,553
	14,352,269		14,769,011
Less: accumulated amortization	(6,131,109	)	(5,544,846	)
	8,221,160		9,224,165

Total amortization expense from intangible assets for the three and nine months ended October 31, 2022 was $334,334 and $1,003,002, respectively (2021 - $342,571 and $1,027,714, respectively). Of the total expense, $2,266 and $6,799 was allocated to inventory (2021 - $2,267 and $6,799, respectively).

During the year ended January 31, 2022, the Company recognized impairment charges of $363,510 on customer relationships allocated to the Oregon reporting unit (Note 4).

Goodwill

As at October 31, 2022, the Company had goodwill of $28,541,323 (January 31, 2022 - $28,541,323) which was allocated to the Nevada reporting unit.

9. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

The following table presents the composition of accounts payable and accrued liabilities:

	October 31, 2022	January 31, 2022
	$	$
Accounts payable	1,375,059	1,402,546
Accrued liabilities	984,215	1,040,914
Interest payable	28,616	65,409
	2,387,890	2,508,869

p. 11

10. LEASES

The Company's leases consist of land and buildings used in the cultivation, processing, and warehousing of its products. All leases were classified as operating leases in accordance with ASC 842.

The following table presents the Company's active leases and total lease term under contract:

Entity Name/Lessee	Asset	Lease term	Type
Silver State Cultivation LLC	Land/Building	12	Operating lease
Silver State Relief LLC (Sparks)	Land/Building	12	Operating lease
Silver State Relief LLC (Fernley)	Land/Building	12	Operating lease
Phantom Distribution, LLC	Land/Building	5	Operating lease
63353 Bend, LLC	Land/Building	5	Operating lease
20727-4 Bend, LLC	Land/Building	5	Operating lease

For the three and nine months ended October 31, 2022, the Company incurred operating lease costs in continuing operations of $350,936 and $1,052,807, respectively (2021 - $350,936 and $1,052,807, respectively). Of these amounts, $203,092 and $609,276 were allocated to inventory, respectively (2021 - $203,092 and $609,276, respectively).

The following table displays the weighted average discount rate used in calculating lease liabilities and weighted average remaining lease term:

	October 31, 2022	January 31, 2022
Weighted average discount rate	10%	10%
Weighted average remaining lease term (years)	9.84	10.46

The maturity of the contractual undiscounted lease liabilities of the Company's operating leases as of October 31, 2022 is as follows:

Year ending January,	$
2023	1,266,900
2024	1,304,907
2025	1,344,054
2026	1,384,376
2027	1,425,907
Thereafter	8,074,293
Total undiscounted lease liabilities	14,800,437
Interest on lease liabilities	(5,760,233	)
Total present value of minimum lease payments	9,040,204
Current portion of lease liability	379,711
Lease liability	8,660,493

As at October 31, 2022, liabilities classified as held for sale includes lease liabilities of $267,090 (January 31, 2022 - $412,093). The Company has total undiscounted lease liabilities with related parties of $14,800,436 (Note 17). Of the total undiscounted lease liabilities, $285,240 are classified as held for sale.

p. 12

11. PROMISSORY NOTES

The Company early adopted ASU 2020-06 on February 1, 2021 using the full retrospective method. The adoption eliminates the cash conversion and beneficial conversion feature models used to separately account for embedded conversion features as a component of equity.

Transaction costs related to the issuance of convertible promissory notes are apportioned to their respective financial liability and equity components (if applicable) in proportion to the allocation of proceeds as a reduction to the carrying amount of each component.

When valuing the financial liability component of the promissory notes, the Company used specific interest rates assuming no conversion features existed. The resulting liability component is accreted to its face value over the convertible note's term until its maturity date.

Convertible promissory notes

The following is a continuity of the Company's convertible promissory notes denominated in U.S. dollars:

	June 13, 2018		May 24, 2019
	issuance		issuance		Total
	$		$		$
Balance, January 31, 2021	1,072,590		1,130,056		2,202,646
Payment	-		(1,210,000	)	(1,210,000	)
Interest expense	17,649		40,685		58,334
Accretion expense	191,203		39,259		230,462
Balance, January 31, 2022	1,281,442		-		1,281,442
Payment	(41,600	)	-		(41,600	)
Interest expense	1,600		-		1,600
Foreign exchange	(85,183	)	-		(85,183	)
Balance, October 31, 2022	1,156,259		-		1,156,259

On June 13, 2018, the Company issued convertible promissory notes to the vendors that sold Eco Firma Farms, LLC ("EFF") to the Company in the aggregate principal amount of $2,000,000. The convertible promissory notes were convertible at $1.00 per share. The convertible promissory notes accrue interest at a rate of 4% per annum, compounded annually, and were fully due and payable on June 13, 2021. The Company is in an ongoing dispute with the vendors over repayment (Note 19). On issuance, the Company determined the conversion feature was a derivative liability as the convertible promissory notes are exercisable in USD while the functional currency of the Company is Canadian dollars. The fair value of the conversion feature as at October 31, 2022 was $nil (January 31, 2022 - $nil).

On May 24, 2019, the Company issued a two-year unsecured convertible promissory note to a debtor of Swell Companies in the principal amount of $1,000,000. The convertible note accrues interest at 10% per annum compounded annually and payable at maturity. The note is convertible into common shares of the Company at a conversion price of $1.56 per share and may be converted at the maturity date. On issuance, the Company determined the conversion feature was a derivative liability as the convertible promissory notes are exercisable in USD while the functional currency of the Company is Canadian dollars. On May 24, 2021 the note was fully repaid.

On August 19, 2022, the Company repaid $41,600 comprised of $40,000 of principal and $1,600 of interest related to the June 13, 2018 issuance of convertible promissory notes.

p. 13

11. PROMISSORY NOTES (Continued)

Promissory note payable

The following is a continuity of the Company's promissory note payable denominated in U.S. dollars:

	January 1, 2019
	issuance
	$
Balance, January 31, 2021	14,186,667
Payments	(6,080,000	)
Balance, January 31, 2022	8,106,667
Payments	(4,560,000	)
Balance, October 31, 2022	3,546,667
Current portion	3,546,667
Non-current portion	-

On January 1, 2019, the Company issued a promissory note to Mr. Newman, who sold Silver State to the Company in the principal amount of $30,000,000. The promissory note is payable in the following principal instalments: $3,000,000 on April 1, 2019, $6,000,000 on each of July 1, 2019, October 1, 2019, January 1, 2020, and April 1, 2020, and $3,000,000 on July 1, 2020. The promissory note accrues interest at a rate of 10% per annum. The promissory note is secured by all of the outstanding membership interests, and a security interest in all of the assets, of Silver State.

On July 1, 2019, the terms of the promissory note payable for the acquisition of Silver State were amended to call for immediate payment of $2,000,000 plus accrued interest on July 1, 2019 followed by payments of $800,000 plus accrued interest on the first of each of August, September, October, November, and December 2019.

Effective November 21, 2019 and June 25, 2020, Mr. Newman and the Company agreed to further amend the terms of the promissory note due to Mr. Newman. The December 1, 2019 principal payment of $800,000 was cancelled and the monthly principal payments thereafter were reduced to $600,000 per month. Further, the annual interest rate on the note was reduced from 10% to 9.5%. The remaining balance on the promissory note is due and payable on January 1, 2021. This modification resulted in a gain of $nil.

On November 19, 2020, the Company announced an agreement with Mr. Newman that the remaining $15,200,000 principal outstanding on his promissory note, due to mature on January 1, 2021, has been amended with lower monthly payments amortized over a 30-month period. Commencing December 1, 2020, the monthly payments are $506,667 plus interest. The interest rate at 9.5% was unchanged.

For the three and nine months ended October 31, 2022, interest expense was $97,058 and $394,561, respectively (2021 - $242,645 and $826,575, respectively). Interest paid during the three and nine months ended October 31, 2022 was $109,322 and $431,354, respectively (2021 - $254,909 and $864,120, respectively).

p. 14

12. DERIVATIVE LIABILITY

The following reflects the continuity of derivative liabilities:

	Conversion feature of convertible promissory notes		Earn out shares		Total
	$		$		$
Balance, January 31, 2021	485,157		9,273,970		9,759,127
Fair value adjustment on derivative liabilities	(485,157	)	(8,091,133	)	(8,576,290	)
Settlement of Phantom earn out	-		(677,939	)	(677,939	)
Effect of foreign exchange	-		501,470		501,470
Balance, January 31, 2022	-		1,006,368		1,006,368
Fair value adjustment on derivative liabilities	-		(757,313	)	(757,313	)
Effect of foreign exchange	-		(29,259	)	(29,259	)
Balance, October 31, 2022	-		219,796		219,796

Upon the February 4, 2019 acquisition of Phantom Farms, the vendors can earn up to 4,500,000 'earn out' shares over a period of seven years. The conditions were based on the Company's common shares exceeding certain share prices during the period. The fair value of the derivative liability is derived using a Monte Carlo simulation. On January 24, 2022, the Company issued 1,300,000 common shares for full settlement of the Phantom earn out shares.

Upon the May 24, 2019 acquisition of Swell Companies, the vendors can earn up to 6,000,000 'earn out' shares over a period of seven years. The conditions were based on the Company's common shares exceeding certain share prices during the period. Additionally, the 50% of the earn out shares are earned upon a change of control of the Company. The fair value of the derivative liability is derived using a Monte Carlo simulation.

Significant inputs into the Monte Carlo simulation used to determine the fair value of earn out shares were as follows:

	Earn out shares October 31, 2022	Earn out shares January 31, 2022
Discount rate	2.65%	1.24%
Expected life in years	3.81	4.33
Expected stock volatility	80%	80%
Expected volatility of foreign exchange	6.29%	6.52%

The conversion feature of the June 13, 2018 and May 24, 2019 convertible promissory notes expired on June 13, 2021 and May 24, 2021, respectively. As such, the fair value of each at October 31, 2022 and January 31, 2022 was $nil.

p. 15

13. SHARE CAPITAL

Share capital consists of one class of fully paid common shares, with no par value. The Company is authorized to issue an unlimited number of common shares. All shares are equally eligible to receive dividends and repayment of capital and represent one vote at the Company's shareholders' meetings.

The following table reflects the continuity of share capital from January 31, 2021 to October 31, 2022:

	Number of Shares	Common stock
		$
Balance, January 31, 2021	117,057,860	103,636,830
Shares issued - Phantom Farm warrants exercises (i)	456,100	533,326
Shares issued - EFF commitment (ii)	19,774	21,787
Shares issued - Guaranteed warrants (iii)	1,214,080	-
Shares issued - Settlement of Earn out shares (iv)	1,300,000	677,939
Share-based compensation	-	366,469
Balance, January 31, 2022	120,047,814	105,236,351
Share-based compensation	-	188,638
Balance, October 31, 2022	120,047,814	105,424,989

(i) On February 4, 2021 the Company issued 456,100 shares upon the exercise of Phantom Farm warrants.

(ii) On April 5, 2021, the Company issued 19,774 common shares to the vendors of EFF for a partial settlement of the Company's commitment to issue shares.

(iii) On June 17, 2021, the Company issued 1,214,080 common shares pursuant to the cashless exercise of 4,160,000 warrants.

(iv) On January 24, 2022, the Company issued 1,300,000 common shares for the settlement of Phantom earn out shares.

Commitment to issue shares

The Company issued a promissory note payable to deliver 2,142,000 shares to the vendors of EFF in the amount of $1,905,635, without interest, any time after October 15, 2018. As at October 31, 2022 shares issued pursuant to this commitment total 793,093 shares.

Warrants

The following summarizes the Company's warrant activity:

	Warrants outstanding		Weighted average exercise price	Weighted average remaining life
	#		C$	Years
Balance January 31, 2021	11,894,746		1.32	1.96
Exercised	(4,616,100	)	1.05
Expired	(4,038,646	)	1.73
Balance, January 31, 2022	3,240,000		1.18	2.10
Balance, October 31, 2022	3,240,000		1.18	1.35

p. 16

13. SHARE CAPITAL (Continued)

As at October 31, 2022, the following warrants were outstanding and exercisable:

Expiry Date	Exercise Price	Number of Warrants
	C$	#
December 31, 2023	1.00	632,400
January 30, 2024	1.00	1,407,600
May 24, 2024	1.50	1,200,000
		3,240,000

On February 4, 2021, 456,100 warrants with an exercise price of $1.17 (C$1.50) were exercised to purchase 456,100 common shares of the Company for proceeds of $533,326. Of the warrants exercised, 426,100 were exercised by a Director of the Company. On the same date, 1,243,900 warrants expired unexercised.

On June 17, 2021, 4,160,000 warrants were exercised on a cashless basis for 1,214,080 common shares of the Company.

Stock options

The Company is authorized to grant options to executive officers and directors, employees, and consultants, enabling them to acquire up to 10% of the issued and outstanding common shares of the Company. The exercise price of each option equals the market price of the Company's shares as calculated on the date of grant. The options can be granted for a maximum term of 10 years. Vesting is determined by the Board of Directors.

Details of the Company's stock option activity are as follows:

	Options outstanding and exercisable		Weighted average exercise price	Weighted average remaining life
	#		C$	Years
Balance January 31, 2021	6,965,000		1.22	2.05
Expired	(1,350,000	)	2.80
Balance, January 31, 2022	5,615,000		0.84	1.45
Granted	600,000		0.70
Expired	(960,000	)	1.25
Balance, October 31, 2022	5,255,000		0.75	1.08

As at October 31, 2022, the following stock options were outstanding and exercisable:

Expiry Date	Exercise Price	Outstanding	Exercisable
	C$	#	#
January 24, 2023	0.80	100,000	100,000
August 17, 2023	0.70	3,905,000	3,905,000
January 28, 2024	1.50	150,000	100,000
October 9, 2024	1.00	500,000	500,000
February 10, 2025	0.70	600,000	199,998
		5,255,000	4,804,998

p. 17

13. SHARE CAPITAL (Continued)

During the three and nine months ended October 31, 2022, the Company recorded a share-based compensation expense of $31,788 and $188,638, respectively (2021 - $67,396 and $321,567, respectively). The fair value of stock options was calculated using the Black-Scholes Option Pricing Model using the following weighted average assumptions:

	2022	2021
Risk-free rate	1.60%	0.19%
Expected life of options	3 years	3 years
Annualized volatility	80%	80%
Dividend rate	0%	0%

The Company has computed the fair value of options granted using the Black-Scholes option pricing model. The expected term used for options issued to non-employees is the contractual life and the expected term used for options issued to employees and directors is the estimated period of time that options granted are expected to be outstanding. The Company utilizes the "simplified" method to develop an estimate of the expected term of "plain vanilla" employee option grants. The Company is utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.

14. SELLING, GENERAL AND ADMINISTRATIVE EXPENSE

Selling, general and administration expenses for the three and nine months ended October 31, 2022 and 2021 comprised of:

	Three months ended October 31,		Nine months ended October 31,
	2022	2021	2022	2021
	$	$	$	$
Accounting and legal	347,618	251,006	581,275	489,543
Depreciation and amortization	341,782	319,561	1,024,354	961,001
License fees, taxes and insurance	377,057	443,894	1,231,435	1,367,544
Office facilities and administrative	84,202	68,488	279,223	180,985
Operating lease cost	147,844	147,844	443,532	443,532
Other expenses	236,395	57,190	558,830	198,398
Professional fees and consulting	240,138	257,904	645,687	537,706
Salaries and wages	676,467	687,582	2,080,531	2,210,808
Sales, marketing, and promotion	26,366	32,363	65,464	60,159
Share-based compensation	31,788	67,396	188,638	321,567
Shareholder communications	4,352	5,497	14,144	22,124
Travel and entertainment	14,770	17,826	43,756	44,962
	2,528,779	2,356,551	7,156,869	6,838,329

p. 18

15. SEGMENTED INFORMATION

The Company defines its major geographic operating segments as Oregon and Nevada. Due to the jurisdictional cannabis compliance issues ever-present in the industry, each state operation is by nature operationally segmented.

Key decision makers primarily review revenue, cost of sales expense, and gross margin as the primary indicators of segment performance. As the Company continues to expand via acquisition, the segmented information will expand based on management's agreed upon allocation of costs beyond gross margin.

Segmented operational activity and balances are as follows:

Nine months ended October 31, 2022	Discontinued operations		Nevada		Corporate		Consolidated
	$		$		$		$
Total revenue	357,540		21,855,358		-		22,212,898
Gross profit	(116,354	)	11,751,307		-		11,634,953
Operating expenses:					-
General and administration	(255,231	)	(3,199,334	)	(2,235,547	)	(5,690,112	)
Sales, marketing, and promotion	(5,858	)	(65,464	)	-		(71,322	)
Operating lease cost	(146,729	)	(443,532	)	-		(590,261	)
Provision for expected credit losses	(35,359	)	-		-		(35,359	)
Depreciation and amortization	(16,837	)	(953,152	)	(71,202	)	(1,041,191	)
Share-based compensation	-		-		(188,638	)	(188,638	)
Impairment of inventory	(61,937	)	-		(20,726	)	(82,663	)
Interest, accretion, and other	(2,042	)	(12,103	)	362,982		348,837
Net income (loss) before taxes	(640,347	)	7,077,722		(2,153,131	)	4,284,244

Entity-wide disclosures

All revenue for the periods ended October 31, 2022 and 2021 was earned in the United States.

For the periods ended October 31, 2022 and year ended January 31, 2022, no customer represented more than 10% of the Company's net revenue.

The following table displays the disaggregation of long-lived tangible assets by geographic area:

	October 31, 2022	January 31, 2022
	$	$
Nevada	11,573,314	11,903,430
Discontinued operations (Oregon)	1,748,286	1,817,633
Other	1,374	24,414
	13,322,974	13,745,477

p. 19

16. COMMITMENTS

The Company and its subsidiaries are committed under lease agreements with third parties and related parties, for land, office space, and equipment in Nevada and Oregon. At October 31, 2022, the Company has the following future minimum payments:

	Third Parties	Related Parties	Total
	$	$	$
2023	68,436	312,090	380,526
2024	273,743	1,276,263	1,550,006
2025	45,551	1,314,551	1,360,102
2026	45,551	1,353,987	1,399,538
2027	45,551	1,394,607	1,440,158
Thereafter	368,202	9,148,937	9,517,139
	847,034	14,800,435	15,647,469

17. RELATED PARTY TRANSACTIONS

Balances due to related parties included in accounts payable, accrued liabilities, and promissory note payable at October 31, 2022 and January 31, 2022:

	October 31, 2022	January 31, 2022
	$	$
Due to the President and CEO	3,575,283	8,172,075
Lease liabilities due to a company controlled by the CEO	9,040,203	9,279,123
Lease liabilities due to SDP Development	-	412,093
Due to the CFO of the Company	1,115	360
	12,616,601	17,863,651

Due to the President and CEO consists of promissory note principal and interest and reimbursable expenses incurred in the normal course of business.

The Company had the following transactions with related parties including key management personnel during the three and nine months ended October 31, 2022 and 2021:

	Three months ended October 31,		Nine months ended October 31,
	2022	2021	2022	2021
	$	$	$	$
Consulting fees paid to a director	75,000	60,000	95,000	180,000
Amounts paid to CEO or companies controlled by CEO	1,992,168	2,128,755	6,072,200	6,545,085
Share based compensation including warrants and stock options for directors and officers	21,108	43,425	132,990	229,364
Lease payments made to SDP Development	-	57,048	-	171,144
	2,088,276	2,289,228	6,300,190	7,125,593

p. 20

17. RELATED PARTY TRANSACTIONS (Continued)

Amounts paid to CEO or companies controlled by CEO consists of salary, lease payments, and promissory note principal and interest.

On February 12, 2020, the Company amended the purchase agreement with SDP Development, of which a Director of the Company is a principal owner. The Company had agreed on February 4, 2019 to purchase SDP Development on October 15, 2020, which owned six real estate properties that were leased in connection with Phantom Farms' cannabis cultivation, processing and wholesale distribution operations. The aggregate purchase price was $8,010,000 payable in cash, or, at the election of the vendors, in whole or in part by the issue of 2,670,000 shares at $3.00 per common share.

18. EARNINGS PER SHARE

The following is a reconciliation for the calculation of basic and diluted earnings per share for the periods ended October 31, 2022 and 2021:

		October 31, 2022			October 31, 2021
Net income from continuing operations after income taxes	$	2,786,987		$	12,209,641
Net loss from discontinued operations after income taxes	$	(374,617	)	$	(261,785	)
Net income	$	2,412,370		$	11,947,856

Weighted average number of common shares outstanding		120,047,814			118,127,232
Dilutive effect of warrants and stock options outstanding		2,833,093			3,453,675
Diluted weighted average number of common shares outstanding		122,880,907			121,580,907

Basic earnings per share, continuing operations	$	0.02		$	0.10
Diluted earnings per share, continuing operations	$	0.02		$	0.10

Basic (loss) income per share, discontinued operations	$	(0.00	)	$	(0.00	)
Diluted (loss) income per share, discontinued operations	$	(0.00	)	$	(0.00	)

Basic earnings per share	$	0.02		$	0.10
Diluted earnings per share	$	0.02		$	0.10

The computation of diluted earnings per share excludes the effect of the potential exercise of warrants and stock options when the average market price of the common stock is lower than the exercise price of the respective warrant or stock option and when inclusion of these amounts would be anti-dilutive. For the nine months ended October 31, 2022 and 2021, the number of warrants and stock options excluded from the computation was 6,004,998 and 5,413,333, respectively.

p. 21

19. CONTINGENCIES

From time to time, the Company is involved in various litigation matters arising in the ordinary course of its business. Management is of the opinion that disposition of any current matter will not have a material adverse impact on the Company's financial position, results of operations, or the ability to carry on any of its business activities.

Legal proceedings

Oregon Action: A complaint was filed in the Oregon State Circuit Court for Clackamas County, on April 29, 2019, by two current owners of Proudest Monkey Holdings, LLC (the former sole member of EFF) (the "Plaintiffs"), alleging contract, employment, and statutory claims, alleging $612,500 in damages (as amended), against the Company, its wholly-owned subsidiaries 320204 US Holdings Corp, EFF, Swell Companies Limited, and Phantom Brands LLC, in addition to three directors, two officers, and one former employee (the "Oregon Action"). The Company and the other defendants wholly denied the allegations and claims made in the lawsuit and is defending the lawsuit. On June 21, 2019, the Company filed Oregon Rule of Civil Procedure ("ORCP") 21 motions to dismiss all of the Plaintiffs' claims against it, its wholly-owned subsidiaries, and other defendants; on May 6, 2020, the court granted the Company's ORCP 21 motion in its entirety to dismiss all of Plaintiffs' claims. The judgment of dismissal was entered by the Clackamas County court on or about October 14, 2020. On November 12, 2020, Plaintiffs filed a notice of appeal of the judgement of dismissal.

On October 22, 2020, the Company submitted a petition to recover the costs and attorney fees incurred by the Company as the prevailing party in the Oregon Action. On January 20, 2021, the Court ruled in the Company's favor, awarding the Company and its subsidiaries $68,195 in attorney's fees, $1,252 in costs, and a statutory prevailing party fee of $640, through a supplemental judgment. On March 3, 2021, Plaintiffs filed an amended notice of appeal from the supplemental judgement awarding attorney fees.

On October 26, 2022, the Oregon Court of Appeals issued a decision reversing the previous judgements and remanding the case to trial court. The Company appealed this decision on December 7, 2022 and awaits resolution of the appeal.

British Columbia Action: On or about September 13, 2019, the Company delivered a notice to the above-mentioned Plaintiffs of alleged breach and default under the EFF purchase and sale agreement, due to alleged unlawful, intentional acts and material misrepresentations by the Plaintiffs before and after the completion of the purchase. As a result of such breach, the Company denied the Plaintiffs' tender of their share payment notes in connection with the agreement. On or about October 14, 2019, Proudest Monkey Holdings, LLC and one of its current owners, sued the Company in the Supreme Court of British Columbia to compel the issuance and delivery of the subject shares, including interests and costs (the "British Columbia Action").

On November 8, 2019, the Company responded and counterclaimed for general, special and punitive damages, including interest and costs, related to breach of contract, repudiation of contract, breach of indemnity and fraudulent and negligent misrepresentation by the Plaintiffs. Plaintiffs filed a response to the Company's counterclaims on or about June 5, 2020, and the parties stipulated to a form of amended pleading which included the joinder of additional parties, an owner of Proudest Monkey Holdings, LLC and EFF, and additional contract and equitable claims and damages, partially duplicative to those alleged by the Plaintiffs in the Oregon lawsuit (breach of contract, indemnity, unjust enrichment and wrongful termination claims). Plaintiffs allege $2,774,176 in damages (as amended), plus unquantified additional damages, interest and costs, of which amounts are partially duplicative of the Oregon Action. This action remains in the discovery stage, but no trial date has been set. It is too early to predict the resolution of the claims and counterclaims.

p. 22

19. CONTINGENCIES (continued)

Settled and Dismissed Action: On or about May 30, 2019, Wallace Hill Partners Ltd. ("Wallace Hill") filed a civil claim in the Supreme Court of British Columbia alleging breach of contract and entitlement to 1,800,000 common shares of the Company, fully vested by March 1, 2019, and damages due to the lost opportunity to sell those shares after such date for a profit. On June 23, 2019, the Company circulated a letter to Wallace Hill terminating the agreement and accepting Wallace Hill's repudiation of the agreement based on Wallace Hill's previously published defamatory comments and termination of the agreement. Also, on June 23, 2019, the Company filed its response to the civil claim denying all claims and filed counterclaims alleging breach of contract, a declaratory judgment of termination of the agreement, defamation and an injunction from further defamatory comments.

On March 23, 2022, the Company and Wallace Hill entered into a mutual release agreement, pursuant to which, among other things, all parties agreed to dismiss their respective claims and to release one another from any further causes of action in connection with the subject matter of the original claims. On April 23, 2022, the parties filed a Notice of Discontinuance in the Supreme Court of British Columbia formally dismissing the civil action.

20. INCOME TAXES

The following table summarizes the Company's income tax expense and effective tax rate for the three and nine months ended October 31, 2022 and 2021:

		Three months ended October 31,				Nine months ended October 31,
		2022		2021		2022		2021
Net income from continuing operations before income taxes	$	1,391,542	$	4,268,511	$	4,924,591	$	15,301,017
Income tax expense	$	1,154,189	$	1,171,331	$	2,137,604	$	3,091,376
Effective tax rate		83%		27%		43%		20%

The Company is subject to income taxes in the United States and Canada. The Company has computed its provision for income taxes based on the actual effective tax rate for the quarter as management believes this is the best estimate for the annual effective tax rate. Significant judgment is required in evaluating the Company's uncertain tax position and determining the provision for income taxes.

21. FINANCIAL INSTRUMENTS

The following tables present information about the Company's financial instruments and their classifications as of October 31, 2022 and January 31, 2022 and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value:

Fair value measurements at October 31, 2022 using:	Level 1	Level 2	Level 3	Total
	$	$	$	$
Financial liabilities:
Earn out shares (Note 12)	-	-	219,796	219,796

Fair value measurements at January 31, 2022 using:	Level 1	Level 2	Level 3	Total
	$	$	$	$
Financial liabilities:
Earn out shares (Note 12)	-	-	1,006,368	1,006,368

The fair value of the derivative liability associated with the earn out shares was derived using a Monte Carlo simulation using non-observable inputs, and therefore represent a level 3 measurement.

p. 23

EX-99.2 3 exhibit99-2.htm EXHIBIT 99.2 C21 Investments Inc.: Exhibit 99.2 - Filed by newsfilecorp.com

C21 INVESTMENTS INC.

	Management’s Discussion and Analysis
	For the three and nine months ended October 31, 2022
	(Expressed in U.S. Dollars)

GENERAL

This Management's Discussion and Analysis ("MD&A") is prepared as of December 15, 2022 and covers the operations of the Company for the three and nine months ended October 31, 2022. This MD&A should be read in conjunction with the Company's unaudited interim condensed consolidated financial statements and accompanying notes for the three and nine months ended October 31, 2022. All inter-company balances and transactions have been eliminated upon consolidation. The Company's financial statements are prepared in accordance accounting principles generally accepted in the United States of America ("GAAP"). Financial information presented in this MD&A is presented in United States dollars ("$" or "US$"), unless otherwise indicated.

The Company's unaudited interim condensed consolidated financial statements for the three and nine months ended October 31, 2022 were authorized for issuance on December 15, 2022 by the Board.

Additional information related to the Company is available for viewing on SEDAR at www.sedar.com or the Company website at www.cxxi.ca.

DESCRIPTION OF BUSINESS

The Company is a vertically integrated cannabis company that cultivates, processes, distributes and sells quality cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets; leveraging industry-leading retail revenues together with high-growth potential and multi-market branded consumer packaged goods ("CPG").

The Company focuses on scalable opportunities in key markets that take advantage of its core competencies, including: (i) retail operational excellence and expanding its retail footprint through value-add acquisitions in existing markets, and (ii) branded CPG expansion through both captive retail and wholesale channels. The Company focuses on acquiring businesses that provide immediate contribution to overall profitability, or have a path to profitability within twelve months, where it can leverage existing assets, brands, and domain expertise.

The Company currently holds licenses in Nevada spanning the entire cannabis supply chain. With the winding down and sale of our Oregon licenses and operations, the Company presents the Oregon operations now as 'held for sale' on the Balance Sheet and as 'discontinued operations' in the Income Statement.

The Company is operated by a management team that has significant professional experience, including deep experience both within the cannabis industry and other fast-paced growth industries like technology and venture capital. Management also includes experts from more traditional industries like forestry, manufacturing, real estate, and capital markets

Strategic Focus and Growth

Our flagship operation in Reno, Nevada under the Silver State Relief brand continues its strong financial performance generating healthy cash flow and satisfied customers. Building around this strong core we have accomplished much in the past 12 months.

- Executed on our capital expansion program in Nevada which included new grow rooms and upgraded lighting in the existing rooms, building out an additional 15,000 sq ft of space (canopy added of 4,800 sq ft). The new rooms together with yield gains from the lighting has doubled the production of high-quality flower to 7,400 lbs/year. Total built out space is now 37,000 sq ft. This project, including the lighting retrofit completed in April 2022, cost $3.0 million. Several old grow rooms have now been closed.

- An additional 30,000 sq ft of cultivation to be built out on expansion of Nevada retail footprint would produce an additional 6,000 lbs/year of high-quality flower.

- Paid down the $30 million secured promissory note (the "Newman Note") owing to the Company's President and Chief Executive Officer to a balance of $3.5 million as at October 31, 2022 ($8.1 million as at January 31, 2022). The balance of the Newman Note is $2.5 million as of December 2, 2022.

p. 2

The Company's strategic Initiatives over the next 12 months include extending our Nevada retail footprint where we have a proven track record of success, continuing our disciplined approach to growth and financing, and internally producing product to expand our Nevada retail footprint, which includes the expansion of our Nevada cultivation operations.

The Company has changed from International Financial Reporting Standards to GAAP starting with the January 31, 2022 audited financial statements, which has been applied retrospectively back to February 1, 2020. Therefore, all the figures and comparative figures in the financial statements and in this MD&A were prepared in GAAP.

With the issuance of the January 31, 2022 audited financial statements, the Oregon operations are presented as discontinued operations. This treatment has been applied retrospectively back to February 1, 2020. As such, the revenue and expenses of the Company now include only the Nevada operations.

NEVADA

The Company acquired Silver State Relief and Silver State Cultivation on January 1, 2019. The Nevada business operates in Sparks and Fernley, Nevada.

CULTIVATION, PROCESSING AND WHOLESALE

Through Silver State Cultivation in Nevada, the Company operates its recently expanded indoor cultivation and processing out of a 104,000 square foot facility now with 37,000 square feet of cultivation and 1,200 square feet dedicated to volatile extraction. Silver State has expanded production up to 10,400 pounds of biomass with flower of 7,400 pounds and trim 3,000 pounds annually. Half of this production will be sold within the Company's Silver State Relief dispensaries.

The Company's extraction processing supports branded CPG in both captive retail and wholesale channels. Silver State manufactures Hood Oil cartridges, Phantom Farms pre-rolls, and flower strains, together with the Silver State branded products which include Flower, pre-rolls, and concentrates. These in-house brands make up over 60% of sales in the dispensaries.

RETAIL

The Company operates two dispensaries, an 8,000-square foot retail dispensary, located in Sparks, and a 6,000-square foot dispensary located in Fernley, Nevada collectively servicing a total of more than 125,000 recreational and medical cannabis customers per quarter, with over 700 SKUs in each store. The Nevada industry has seen sales slow since a peak in March/April 2021. Silver State had total retail sales of $32.4 million during the year ended January 31, 2022 as compared to $32.9 million in the prior year.

p. 3

RESULTS OF OPERATIONS

Summary derived from the Company's audited consolidated financial statements:

PROFIT AND LOSS		3 months ended October 31,						9 months ended October 31,
		2022			2021			2022			2021
Revenue	$	7,207,404		$	7,938,188		$	21,855,358		$	25,328,410
Inventory expensed to cost of sales		3,303,066			3,485,632			10,104,051			10,485,735
Gross profit		3,904,338			4,452,556			11,751,307			14,842,675
		54.2%			56.1%			53.8%			58.6%
Expenses
General and administration		1,980,999			1,789,387			5,434,881			5,052,070
Sales, marketing, and promotion		26,366			32,363			65,464			60,160
Operating lease cost		147,844			147,844			443,532			443,532
Depreciation and amortization		341,782			319,561			1,024,354			961,001
Share based compensation		31,788			67,396			188,638			321,567
Total expenses		2,528,779			2,356,551			7,156,869			6,838,330

Income from operations		1,375,559			2,096,005			4,594,438			8,004,345
Other items
Interest expense		(98,657	)		(242,645	)		(396,161	)		(870,952	)
Accretion expense		-			-			-			(230,462	)
Other Income (loss)		(13,173	)		23,132			(30,999	)		137,738
Change in fair value of derivative liabilities		127,813			2,392,019			757,313			8,260,347

Income (loss) before undernoted		1,391,542			4,268,511			4,924,591			15,301,016
Net income (loss) from discontinued operations		11,154			(325,237	)		(374,617	)		(328,067	)
Provision for income taxes		(1,154,189	)		(1,105,542	)		(2,137,604	)		(3,025,094	)
Net income (loss)	$	248,507			2,837,732			2,412,370			11,947,855

Cumulative translation adjustment		305,354			(21,737	)		88,967			(854,280	)
Income (loss) and comprehensive income (loss) for the period		553,861			2,815,995			2,501,337			11,093,575

The Company has adopted GAAP as of January 31, 2022 with effect retroactively to February 1, 2020. All the current and comparative figures are in GAAP.

"Revenue" includes retail revenues from our two stores and wholesale revenue from our cultivation operations. Third Quarter 2023 ("Q3") revenues declined versus prior year Q3-2022 by 9% to $7.2 million. Revenues for the 9 months ended October 31, 2022 declined versus the prior year by 14% to $21.9 million. This is consistent with industry trends since the easing of pandemic restrictions. This trend is also consistent with the State of Nevada industry figures.

"Cost of Sales" includes the costs directly attributable to cultivating and processing cannabis plus the cost of product purchases from third parties, for sale in our stores. With the expansion of our cultivation facility our costs to produce have increased, but the production cost per pound has started to come down due to economies of scale. We use an average costing model which captures and averages costs over several quarters.

"Gross profit" fell in Q3 versus prior year Q2 from 56% to 54%, mainly due to weaker demand and a decline in retail selling prices. Gross profit fell in the nine months ended October 31, 2022 versus the prior year period from 59% to 54%.

"Income from operations" for Q3 decreased to $1.4 million, down 34% versus prior year Q3 of $2.1 million. Income from operations in the nine months ended October 31, 2022 decreased to $4.6 million, down 43% versus the prior year period of $8.0 million.

p. 4

Expenses

"General and administration" includes all overhead costs that have not otherwise been allocated to cost of sales. These include salaries and wages, professional fees including legal and accounting, insurance, and some local taxes. Q3 costs increased by $191,612 as compared to prior year Q3 due to increased professional fees. Costs for the nine months ended October 31, 2022 increased versus the same period last year by $382,811.

"Operating lease cost" is the cost of our leases not included in cost of sales and was $147,844, unchanged from prior year Q2, and unchanged in the nine months ended October 31, 2022 versus the prior year period.

"Depreciation and amortization" include provisions for fixed assets and intangibles not included in cost of sales. The total depreciation and amortization in Q3 was $341,782 versus $319,561 in prior year Q3. Total depreciation and amortization for the nine months ended October 31, 2022 was $1,024,354 versus $961,001 in the prior year period.

"Share based compensation" is a non-cash item and reflects the issuance of stock options to employees, officers and directors.

Other Items

"Interest expense" in Q3 was $98,657 versus $242,645 in prior year Q3. Interest expense for the nine months ended October 31, 2022 was $396,161 versus $870,952 in the prior year period. These decreases reflect the reduction in interest bearing debt during the period.

"Change in fair value of derivative liabilities" is a periodic revaluation of the earn out shares outstanding to vendors of businesses purchased by the Company. These earn out shares are revalued using a Monte Carlo simulation. The fair value of this liability will increase with an increase in the stock price of the Company and vice-versa. The change in fair value must be recorded through the Company's profit or loss statement. As a result, a share price increase period-over-period, will result in a reduction in net income and vice-versa.

"Net income (loss) from discontinued operations" the Company has classified all revenues and expenses pertaining to its Oregon operations to 'discontinued operations'. This treatment has been applied to all the current and comparative figures above.

"Provision for income taxes" for Q3 of $1,154,189 versus $1,105,542 in the previous year Q3. In the nine months ended October 31, 2022 the provision for income taxes was $2,137,604 versus $3,025,094 in the prior year period.

"Other comprehensive income (loss)," specifically the cumulative translation adjustment, comes about in GAAP when translating the balances between the parent company (investments made in C$) and the US subsidiaries (US$). These foreign exchange gains or losses at each reporting date result from the translation of C$ amounts to US$ (which is our reporting currency).

p. 5

Adjusted EBITDA

The adjusted EBITDA figures below are presented in GAAP and with the Oregon operations categorized as "discontinued". Both these changes took effect with the preparation of the January 31, 2022 audited financial statements and were applied retroactively back to February 1, 2020.

ADJUSTED EBITDA - Quarters ending
	31-Oct-22		31-Jul-22		30-Apr-22		31-Jan-22		31-Oct-21		31-Jul-21

Net income (loss)	248,507		1,857,043		306,820		(1,031,705	)	2,837,732		4,061,818

Interest & accretion	98,657		133,455		164,049		206,116		242,645		376,752
Provision for taxes	1,154,189		485,152		498,263		948,152		1,105,542		981,782
Depreciation and amortization	341,782		341,286		341,286		319,445		319,561		320,807
Depreciation and interest in COS	203,093		203,091		203,092		203,093		203,092		203,091
EBITDA	2,046,228		3,020,027		1,513,510		645,101		4,708,572		5,944,250

Change in FV of derivative liability	(127,813	)	(629,500	)	-		(315,943	)	(2,392,019	)	(2,746,018	)
Share based compensation	31,788		54,064		102,786		44,902		67,396		112,455
Loss (gain) discontinued operations	(11,154	)	(344,554	)	730,325		1,914,577		325,237		176,135
One-time special project costs	206,459		89,331		50,000		-		229,069		-
Other gain/loss	13,173		21,972		(4,146	)	29,268		(23,132	)	5,327
Adjusted EBITDA	2,158,681		2,211,340		2,392,475		2,317,905		2,915,123		3,492,149

Non-GAAP Financial Measures

"Adjusted EBITDA" is supplemental, non-GAAP financial measures. The Company defines EBITDA as earnings before depreciation and amortization, depreciation and interest in cost of sales, income taxes, and interest. Additionally, the Company's Adjusted EBITDA presented above excludes accretion, loss from discontinued operations, one-time transaction costs and all other non-cash items. The Company has presented "Adjusted EBITDA" because its management believes it is a useful measure for investors when assessing and considering the Company's continuing operations and prospects for the future. Furthermore, "Adjusted EBITDA" is a commonly used measurement in the financial community when evaluating the market value of similar companies. "Adjusted EBITDA" is not a measure of performance calculated in accordance with GAAP, and these metrics should not be considered in isolation of, or as a substitute for, the measurement of the Company's performance prepared in accordance with GAAP. "Adjusted EBITDA," as calculated and reconciled in the table above, may not be comparable to similarly titled measurements used by other issuers and is not necessarily a measure of the Company's ability to fund its cash needs. Figures have been restated to match current presentation.

p. 6

SELECTED QUARTERLY INFORMATION

The following table summarizes selected consolidated financial information of the Company for the preceding eight quarters.

SUMMARY OF QUARTERLY RESULTS
		31-Oct-22			31-Jul-22			30-Apr-22			31-Jan-22
Total assets	$	61,284,437		$	61,703,793		$	61,580,422		$	61,853,474
Working capital (deficiency)	$	(3,900,919	)	$	(4,823,405	)	$	(5,679,998	)	$	(4,444,076	)
Shareholders' equity (deficiency)	$	37,673,167		$	37,087,518		$	35,395,618		$	34,983,192
Revenue	$	7,207,404		$	7,175,493		$	7,472,461		$	7,654,566
Net income (loss)	$	248,507		$	1,857,043		$	306,820		$	(1,031,705	)
Net income (loss) per share		0.00			0.02			0.00			(0.01	)
		31-Oct-21			31-Jul-21			30-Apr-21			31-Jan-21
Total assets	$	64,315,094			65,317,561			66,261,274			66,819,464
Working capital (deficiency)	$	(5,133,865	)		(4,632,617	)		(4,014,559	)		(3,914,024	)
Shareholders' equity (deficiency)	$	35,204,614			32,321,225			28,043,749			23,256,148
Revenue	$	7,938,188			8,592,872			8,797,350			8,811,046
Net income (loss)	$	2,837,732			4,061,818			5,048,306			(7,314,184	)
Net income (loss) per share		0.02			0.03			0.04			(0.07	)

Quarter ended October 31, 2022 (Q3)

Total assets decreased slightly during the Quarter. Mainly from accretion and amortization of assets.

Working capital deficiency improved to $3.9 million during Q3, positive operations cash flow was offset by debt and interest payments and increase in income taxes payable.

Shareholders equity increased to $37.7 million from $37.1 million during Q3.

Revenue increased sequentially from Q2-2023 to current Q3-2023 by 0.4%, which is bucking the industry trends. Industry website, BDSA reports a sequential 15% decline in Nevada industry sales from Q2-2023 to Q3-2023. BDSA also reports a 24% decline in Nevada retail sales from quarter ending October 2021 to quarter ending October 2022, while C21 revenues have fallen by 9% in the same period. Currently, delivery and curbside pick-up continue to account for about 21% of transactions and 25% of revenue.

Net Income (loss) decreased sequentially in Q3-2023 to $0.25 million from $1.86 million in Q2-2023 due to slightly less income from operations, negative adjustments in the tax provision and a smaller gain on derivative liabilities.

p. 7

CONTRACTUAL OBLIGATIONS

The following table includes the Company's obligations to make future payments for each of the next five years that represent contracts and other commitments that are known and committed:

CONTRACTUAL OBLIGATIONS
		Carrying amount		Contractual cash flows		Under 1 year		1-3 years		3-5 years		More than 5 years
As at October 31, 2022
Trade and other payables	$	2,387,890	$	2,387,890	$	2,387,890	$	-	$	-	$	-
Finance lease payments (1)		9,040,204		15,085,677		1,495,092		2,706,009		2,810,283		8,074,292
Convertible debt (2)		1,156,259		1,156,259		1,156,259		-		-		-
Notes and other borrowings (3)		3,983,699		4,108,460		3,592,218		91,102		91,102		334,038
Total	$	16,568,052	$	22,738,286	$	8,631,459	$	2,797,111	$	2,901,385	$	8,408,330

(1) Amounts in the table reflect minimum payments due for the Company's leased facilities and certain leased equipment under various lease agreements and purchase agreements.

(2) Amounts in the table reflect the contractually required principal payments payable under a convertible promissory note agreement.

(3) Amounts in the table reflect the contractually required principal payments payable under a promissory note issued to the vendor that sold Silver State to the Company, and miscellaneous debt.

COVID-19 GLOBAL PANDEMIC

On March 11, 2020, the World Health Organization ("WHO") declared the novel coronavirus contagious disease outbreak and related adverse public health developments ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. While the continued severity of the pandemic and its impact on the economic environment is uncertain, the Company continues to monitor its status closely. The Company's priority during the COVID-19 pandemic is the protection and safety of its employees and customers and it continues to follow the recommended guidelines of applicable government and health authorities. Despite being deemed as an essential retailer in its core markets, the Company experienced a negative impact on FY 2022 sales in certain markets.

COVID-19 may continue to materially impact the Company, including its ability, and the ability of its suppliers and distributors, to effectively manage the restrictions, limitations and health issues presented by the COVID-19 pandemic, the ability to continue its production, distribution and wholesale sale of its products and the demand for and use of its products by consumers, disruptions to the global and local economies due to related stay-at-home orders, quarantine policies and restrictions on travel, trade and business operations and a reduction in discretionary consumer spending. The Company continues to closely monitor the ongoing impacts of COVID-19, in particular regarding the global supply chain for both COVID-19 and other reasons, and the retail sector.

The Company takes all reasonable steps to ensure staff are appropriately informed and trained to promote a culture of health, safety, and continuous improvement, especially during these difficult times for public health and safety due to the COVID-19 pandemic. Wherever possible, the Company will continue to adopt generally accepted health and safety best practices from non-cannabis-related industries and follows all health and safety guidelines issued by the United States Centers for Disease Control and all orders from relevant provincial, state and local jurisdictions and authorities.

ADDITIONAL INFORMATION

LEGAL PROCEEDINGS

Regarding the Oregon claims brought by Proudest Monkey Holdings, LLC and its current owners (the former owners of Eco Firma Farms LLC) (collectively the "Plaintiffs"), the Oregon Court of Appeals, by written opinion dated October 26, 2022, reversed the dismissal of Plaintiffs' claims against the Company's subsidiaries and remanded the claims to the Oregon State Circuit Court for Clackamas County. The Company recently filed a Petition for Reconsideration with the Oregon Court of Appeals.

p. 8

For a summary of the current legal proceedings, please refer to the Company's MD&A for the years ended January 31, 2022 and 2021 for detailed disclosure in this regard.

OFF-BALANCE SHEET ARRANGEMENTS

As of the date of this report, the Company has not entered into any off-balance sheet arrangements.

DISCLOSURE OF OUTSTANDING SHARE DATA

The Company's authorized share capital consists of an unlimited number of common shares without par value.

As of October 31, 2022, there were:

- 120,047,814 Common Shares issued and outstanding;

- 5,255,000 options outstanding to purchase Common Shares, of which 4,804,998 options had vested;

- 3,240,000 warrants outstanding to purchase Common Shares; and

- no restricted share units ("RSUs") outstanding to purchase Common Shares.

As of December 15, 2022 (the date of this MD&A) the Company had the following securities outstanding:

Type of Security	Number outstanding
Common Shares	120,047,814
Stock Options	5,255,000
Warrants	3,240,000
Acquisition shares	793,093
	129,335,907

MANAGEMENT'S RESPONSIBILITY FOR FINANCIAL INFORMATION

The Company's financial statements and the other financial information included in this MDA are the responsibility of the Company's management and have been examined and approved by the Board. The accompanying audited financial statements are prepared by management in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These consolidated financial statements have been prepared on an accrual basis and are based on historical costs, except for certain financial instruments classified as fair value through profit or loss, and include certain amounts based on management's best estimates using careful judgment. The selection of accounting principles and methods is management's responsibility. Management recognizes its responsibility for conducting the Company's affairs in a manner that complies with the requirements of applicable laws and established financial standards and principles and maintains proper standards of conduct in its activities. The Board supervises the financial statements and other financial information through its audit committee, which is comprised of a majority of non-management directors.

The audit committee's role is to examine the financial statements and recommend that the Board approve them, to examine the internal control and information protection systems, and all other matters relating to the Company's accounting and finances. To do so, the audit committee meets annually with the external auditors, with or without the Company's management, to review their respective audit plans and discuss the results of their examination. This committee is responsible for recommending the appointment of the external auditors or the renewal of their engagement.

p. 9

ACCOUNTING POLICIES AND ESTIMATES

FINANCIAL RISK MANAGEMENT

The Board approves and monitors the risk management processes of the Company, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

CREDIT RISK

Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company's primary exposure to credit risk is on its cash held in bank accounts, accounts receivable, and its notes receivable from acquisition targets. The Company's cash is deposited in bank accounts held with a bank in Canada, a trust company in Canada, and three credit unions in Nevada, Washington and Colorado; and accordingly, there is a concentration of credit risk. This risk is managed by using a bank that is a high credit quality financial institution as determined by rating agencies. The Company's notes receivables are placed with acquisition targets that are under definitive agreements, in which closing is based primarily on receipt of regulatory approval. If an unlikely event occurred which delayed regulatory approval for an extended period of time or permanently, the risk of default on these notes would be increased based on the liquidity of the acquisition targets.

LIQUIDITY RISK

Liquidity risk is the risk that the Company will not be able to meet its obligations as they become due. The Company's ability to continue as a going concern is dependent on management's ability to raise required funding through future equity or debt issuances. The Company manages its liquidity risk by forecasting cash flows from operations and anticipating any investing and financing activities. Management and the Board are actively involved in the review, planning and approval of significant expenditures and commitments.

The Company's consolidated financial statements for three and nine months ended October 31, 2022, have been prepared on a going concern basis, which assumes that the Company will be able to continue its operations and realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

The Company reports an accumulated deficit of $66,097,963, and a working capital deficit of $3,900,919 as at October 31, 2022.

The Company has generated significant positive cash flow for the three and nine months ended October 31, 2022, and the fiscal year ended January 31, 2022. The Statement of Cash Flows for the nine months ended October 31, 2022, has cash provided by continuing operations of $4.8 million ($8.4 million - year ended January 31, 2022). Management has taken several actions to ensure that the Company will continue as a going concern through October 31, 2023, including the closing of its operations in Oregon, selling the assets in Oregon, reducing headcount, and reducing discretionary expenditures. The Company is seeking additional financing in the form of debt which could consolidate existing debt on its balance sheet on more favorable terms. Management believes that these actions will enable the Company to continue as a going concern through December 15, 2023, one year from the date these consolidated financial statements were issued.

There remains uncertainty about the U.S. federal government's position on cannabis with respect to cannabis-legal states. A change in its enforcement policies could impact the ability of the Company to continue as a going concern and have a material adverse impact on the business.

INTEREST RATE RISK

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not subject to any interest rate volatility as its long-term debt instruments and convertible notes are carried at a fixed interest rate throughout their term.

CAPITAL MANAGEMENT

The Company's objectives when managing its capital are to ensure there are enough capital resources to continue operating as a going concern and maintain the Company's ability to ensure sufficient levels of funding to support its ongoing operations and development. The purpose of these objectives is to provide continued returns and benefits to the Company's shareholders. The Company's capital structure includes items classified in debt and shareholders' equity.

p. 10

The Board does not establish quantitative return on capital criteria for management, but rather relies on the expertise of the Company's management to sustain future development of the business considering changes in economic conditions and the risk characteristics of the Company's underlying asset.

The Company works with its capital advisors, Needham & Company based in California and CB1 Capital based in New York, to identify the best strategic options to execute our corporate growth plans, as well as increasing financial flexibility in managing our debt.

U.S. INDUSTRY BACKGROUND AND REGULATORY ENVIRONMENT

INDUSTRY BACKGROUND AND TRENDS

The emergence of the legal cannabis sector in the United States, both for medical and adult use, has been rapid as more states adopt regulations for its production and sale. Today 60% of Americans live in a state where cannabis is legal in some form and almost a quarter of the population lives in states where it is fully legalized for adult use.

The use of cannabis and cannabis derivatives to treat or alleviate the symptoms of a wide variety of chronic conditions has been generally accepted by a majority of citizens with a growing acceptance by the medical community as well. A review of the research, published in 2015 in the Journal of the American Medical Association, found evidence that cannabis can treat pain and muscle spasms. The pain component is particularly important, because other studies have suggested that cannabis can replace patients' use of highly addictive, potentially deadly opiates - meaning cannabis legalization literally improves lives.

Polls throughout the United States consistently show overwhelming support for the legalization of medical cannabis, together with strong majority support for the full legalization of recreational adult-use cannabis. It is estimated that 94% of U.S. voters support legalizing cannabis for medical use. In addition, 66% of the U.S. public supports legalizing cannabis for adult recreational use. These are large increases in public support over the past 40 years in favor of legalized cannabis use.

Notwithstanding that 36 states and the District of Columbia have now legalized adult-use and/or medical cannabis, cannabis remains illegal under U.S. federal law with cannabis listed as a Schedule I drug under the U.S. Federal Controlled Substances Act of 1970 ("CSA").

Currently the Company only operates in the state of Nevada. The Company may expand internally within Nevada or into other states within the United States that have legalized cannabis use either medicinally or recreationally and expand internationally.

FEDERAL REGULATORY UPDATE

For a complete summary of the Federal regulatory environment, please refer to the Company's MDA for the years ended January 31, 2022, and 2021, for detailed disclosure in this regard.

NEVADA REGULATORY UPDATE

For a summary of the Nevada regulatory environment, please refer to the Company's MDA for the years ended January 31, 2022, and 2021, for detailed disclosure in this regard.

p. 11

RISK FACTORS

For a comprehensive list of the risk factors relating to the business and securities of the Company, please refer to the Company's MDA for the years ended January 31, 2022 and 2021 for detailed disclosure in this regard. The Company will face a few challenges and significant risks in the development of its business due to the nature of and present stage of its business. These risks and uncertainties are not the only ones facing the Company. Additional risks and uncertainties not presently known to the Company or currently deemed immaterial by the Company, may also impair the operations of or materially adversely affect the securities of the Company. If any such risks occur, the Company's shareholders could lose all or part of their investment and the business, financial condition, liquidity, results of operations and prospects of the Company could be materially adversely affected. Some of the risk factors previously disclosed are interrelated and, consequently, readers should read such risk factors in connection with one another.

The acquisition of any of the securities of the Company is speculative, involving a high degree of risk and should be undertaken only by persons whose financial resources are enough to enable them to assume such risks and who have no need for immediate liquidity in their investment. An investment in the securities of the Company should not constitute a major portion of a person's investment portfolio and should only be made by persons who can afford a total loss of their investment.

FORWARD LOOKING STATEMENTS

This Management's Discussion and Analysis includes "forward-looking information" and "forward-looking statements" within the meaning of Canadian securities laws and United States securities laws. All information, other than statements of historical facts, included in this MDA that addresses activities, events or developments that the Company expects or anticipates will or may occur in the future is forward-looking information. Forward-looking information includes, among other things, information regarding: statements relating to the business and future activities of, and developments related to, the Company, including such things as the ongoing impact of the COVID-19 pandemic with reductions of operating (including marketing) and capital expenses and revenues, future business strategy, competitive strengths, goals, expansion and growth of the Company's business, operations and plans, including the Company's positioning in the United States cannabis industry, including the continued performance of the Company's operations generally, and specifically its Nevada retail operations, including the continued profitability of the Company's Nevada operations, including the Company's ability to continue to service its debt through operating cash flows, including the Company's ability to pursue growth opportunities and generate future growth for the Company by scaling and replicating its profitable model in Nevada, including the Company's ability of to secure non-dilutive debt financing, including the continued performance of the Company's brands and the expectations as to the development and distribution of the Company's brands and products, including the continued demand for cannabis products, including the timing of the completion of any acquisitions or dispositions and expectations of whether such proposed transactions will be consummated on the current terms or otherwise and contemplated timing, expectations and effects of such proposed transactions, estimates of future cultivation, manufacturing and extraction capacity, expectations as to the development and distribution of the Company's brands and products, the expansion into additional U.S. and international markets, any potential future legalization of adult-use and/or medical cannabis under U.S. federal law, expectations of market size and growth in the United States and the states in which the Company operates or contemplates future operations and the effect such growth will have on the Company's financial performance, expectations for other economic, business, regulatory and/or competitive factors related to the Company or the cannabis industry generally, and other events or conditions that may occur in the future.

Readers are cautioned that forward-looking information and statements are based on reasonable assumptions, estimates, analysis and opinions of management of the Company at the time they were provided or made in light of their experience and their perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information and statements.

Forward-looking information and statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management at the date the statements are made including among other things assumptions about: the contemplated acquisitions and dispositions being completed on the current terms and current contemplated timeline; development costs remaining consistent with budgets; ability to manage anticipated and unanticipated costs; favorable equity and debt capital markets; the ability to raise sufficient capital to advance the business of the Company; favorable operating and economic conditions; political and regulatory stability; obtaining and maintaining all required licenses and permits; receipt of governmental approvals and permits; sustained labor stability; favorable production levels and costs from the Company's operations; the pricing of various cannabis products; the level of demand for cannabis products; the availability of third party service providers and other inputs for the Company's operations; the Company's ability to conduct operations in a safe, efficient and effective manner; the ability of the Company to restructure and service its secured debt; the availability of the Company to secure a non-dilutive debt financing on terms acceptable to the Company; and the ability of the Company's operations to continue to perform and continue in the ordinary course in light of the ongoing COVID-19 pandemic. While the Company considers these assumptions to be reasonable, the assumptions are inherently subject to significant business, social, economic, political, regulatory, competitive and other risks, uncertainties, contingencies and other factors that could cause actual performance, achievements, actions, events, results or conditions to be materially different from those projected in the forward-looking information and statements. Many assumptions are based on factors and events that are not within the control of the Company and there is no assurance they will prove to be correct.

p. 12

Risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information and statements include, among others, risks relating to U.S. regulatory landscape and enforcement related to cannabis, including governmental and environmental regulation, public opinion and perception of the cannabis industry, risks related to the ability to consummate any proposed acquisitions or dispositions on the proposed terms and the ability to obtain requisite regulatory approvals and third party consents and the satisfaction of other conditions, risks related to reliance on third party service providers, the limited operating history of the Company, risks inherent in an agricultural business, risks related to proprietary intellectual property, risks relating to financing activities, risks relating to the management of growth, increasing competition in the cannabis industry, risks associated to cannabis products manufactured for human consumption including potential product recalls, reliance on key inputs, suppliers and skilled labor (the availability and retention of which is subject to uncertainty), cybersecurity risks, ability and constraints on marketing products, fraudulent activity by employees, contractors and consultants, risk of litigation and conflicts of interest, and the difficulty of enforcement of judgments and effecting service outside of Canada, limited research and data relating to cannabis, risks and uncertainties related to the impact of the COVID-19 pandemic and the impact it may continue to have on the global economy and the retail sector, particularly the cannabis retail sector in the states in which the Company operates, as well as those risk factors discussed elsewhere herein, including under "Risk Factors".

Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such forward-looking information and statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such information and statements. Accordingly, readers should not place undue reliance on forward-looking information and statements.

While the Company may elect to update such forward-looking information and statements at a future time, it assumes no obligation for doing so except to the extent required by applicable law.

p. 13

EX-99.3 4 exhibit99-3.htm EXHIBIT 99.3 C21 Investments Inc.: Exhibit 99.3 - Filed by newsfilecorp.com

This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada's changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on or after January 1, 2011. This document is for reference purposes only and is not an official statement of the law.

Form 52-109FV2

Certification of Interim Filings

Venture Issuer Basic Certificate

I, Sonny Newman, Chief Executive Officer of C21 Investments Inc., certify the following:

1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of C21 Investments Inc. (the "issuer") for the interim period ended October 31, 2022.

2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

Date: December 15, 2022

SIGNED: "Sonny Newman"

Sonny Newman, Chief Executive Officer

NOTE TO READER

In contrast to the certificate required for non-venture issuers under National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings (NI 52-109), this Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as defined in NI 52-109. In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of

i) controls and other procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

ii) a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.

The issuer's certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&P and ICFR as defined in NI 52-109 may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.

EX-99.4 5 exhibit99-4.htm EXHIBIT 99.4 C21 Investments Inc.: Exhibit 99.4 - Filed by newsfilecorp.com

Form 52-109FV2

Certification of Interim Filings

Venture Issuer Basic Certificate

I, Michael Kidd, Chief Financial Officer of C21 Investments Inc., certify the following:

Date: December 15, 2022

SIGNED: "Michael Kidd"

Michael Kidd, Chief Financial Officer

NOTE TO READER

ii) a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.

GRAPHIC 6 exhibit99-1x001.jpg GRAPHIC begin 644 exhibit99-1x001.jpg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end GRAPHIC 7 exhibit99-1xu001.jpg GRAPHIC begin 644 exhibit99-1xu001.jpg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

7_ (+J?_('T?15;3+J2^TVTN98&M99HDD>!_O1D@$J<@59KG/>3NKH****!A1110 4444 %%%% !1110!__9 end GRAPHIC 8 exhibit99-1xu002.jpg GRAPHIC begin 644 exhibit99-1xu002.jpg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end GRAPHIC 9 exhibit99-2x001.jpg GRAPHIC begin 644 exhibit99-2x001.jpg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end GRAPHIC 10 exhibit99-2xu002.jpg GRAPHIC begin 644 exhibit99-2xu002.jpg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end GRAPHIC 11 exhibit99-2xu003.jpg GRAPHIC begin 644 exhibit99-2xu003.jpg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end